Should Antibiotic Prophylaxis Be Routinely Used in Patients with Antibody-Mediated Primary Immunodeficiency?

TY - JOUR

T1 - Should Antibiotic Prophylaxis Be Routinely Used in Patients with Antibody-Mediated Primary Immunodeficiency?

AU - Ballow, Mark

AU - Paris, Kenneth

AU - de la Morena, Maite

N1 - Funding Information: Conflicts of interest: M. Ballow is on the data and safety monitoring boards for Prometric, CSL Behring, and Green Cross; has received consultancy fees from Baxalta; has received research support from CSL Behring and Grifols; has received lecture fees from Baxalta, Grifols, and CSL Behring; and has served as a Consultant Medical Director for the Immune Deficiency Foundation. K. Paris has received consultancy fees from Shire and CSL Behring; has received lecture fees, payment for developing educational presentations, and travel support from Shire; and is an Immune Deficiency Foundation Advocacy Committee member. M. de la Morena has received research support from the Jeffrey Modell Foundation, National Institutes of Health (grant no. 5R01AI114523).

PY - 2018/3

Y1 - 2018/3

UR - http://www.scopus.com/inward/record.url?scp=85038841681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038841681&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2017.11.024

DO - 10.1016/j.jaip.2017.11.024

M3 - Review article

C2 - 29274825

AN - SCOPUS:85038841681

SN - 2213-2198

VL - 6

SP - 421

EP - 426

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 2

ER -